Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 141

1.

Hospital readmission with Clostridium difficile infection as a secondary diagnosis is associated with worsened outcomes and greater revenue loss relative to principal diagnosis: A retrospective cohort study.

Zilberberg MD, Nathanson BH, Marcella S, Hawkshead JJ 3rd, Shorr AF.

Medicine (Baltimore). 2018 Sep;97(36):e12212. doi: 10.1097/MD.0000000000012212.

2.

Impaired Quality of Life, Work, and Activities Among Adults with Clostridium difficile Infection: A Multinational Survey.

Heinrich K, Harnett J, Vietri J, Chambers R, Yu H, Zilberberg M.

Dig Dis Sci. 2018 Nov;63(11):2864-2873. doi: 10.1007/s10620-018-5222-1. Epub 2018 Aug 3.

PMID:
30074110
3.

Development and validation of a bedside instrument to predict carbapenem resistance among gram-negative pathogens in complicated urinary tract infections.

Zilberberg MD, Nathanson BH, Sulham K, Fan W, Shorr AF.

Infect Control Hosp Epidemiol. 2018 Sep;39(9):1112-1114. doi: 10.1017/ice.2018.166. Epub 2018 Jul 31.

PMID:
30060775
4.

Epidemiology and Outcomes of Hospitalizations With Invasive Aspergillosis in the United States, 2009-2013.

Zilberberg MD, Nathanson BH, Harrington R, Spalding JR, Shorr AF.

Clin Infect Dis. 2018 Aug 16;67(5):727-735. doi: 10.1093/cid/ciy181.

PMID:
29718296
5.

30-day readmission, antibiotics costs and costs of delay to adequate treatment of Enterobacteriaceae UTI, pneumonia, and sepsis: a retrospective cohort study.

Zilberberg MD, Nathanson BH, Sulham K, Fan W, Shorr AF.

Antimicrob Resist Infect Control. 2017 Dec 6;6:124. doi: 10.1186/s13756-017-0286-9. eCollection 2017.

6.

Treatment Trends and Outcomes in Healthcare-Associated Pneumonia.

Haessler S, Lagu T, Lindenauer PK, Skiest DJ, Priya A, Pekow PS, Zilberberg MD, Higgins TL, Rothberg MB.

J Hosp Med. 2017 Nov;12(11):886-891. doi: 10.12788/jhm.2877.

PMID:
29091975
7.

The Answer for Inhaled Antibiotics in Pneumonia Is Still Blowing in the Wind.

Shorr AF, Zilberberg MD.

Chest. 2017 Jun;151(6):1201-1203. doi: 10.1016/j.chest.2016.11.034. No abstract available.

PMID:
28599925
8.

Daily cost of delay to adequate antibiotic treatment among patients surviving a hospitalization with community-onset Acinetobacter baumannii pneumonia or sepsis.

Zilberberg MD, Nathanson BH, Sulham K, Fan W, Shorr AF.

Crit Care. 2017 Jun 5;21(1):130. doi: 10.1186/s13054-017-1719-9. No abstract available.

9.

Carbapenem resistance, inappropriate empiric treatment and outcomes among patients hospitalized with Enterobacteriaceae urinary tract infection, pneumonia and sepsis.

Zilberberg MD, Nathanson BH, Sulham K, Fan W, Shorr AF.

BMC Infect Dis. 2017 Apr 17;17(1):279. doi: 10.1186/s12879-017-2383-z.

10.

Recurrent Clostridium difficile infection among Medicare patients in nursing homes: A population-based cohort study.

Zilberberg MD, Shorr AF, Jesdale WM, Tjia J, Lapane K.

Medicine (Baltimore). 2017 Mar;96(10):e6231. doi: 10.1097/MD.0000000000006231.

11.

Continuous infusion of beta-lactams: a blissful option for the intensive care unit.

Shorr AF, Zilberberg MD.

J Thorac Dis. 2016 Dec;8(12):E1637-E1640. doi: 10.21037/jtd.2016.12.47. No abstract available.

12.

Viruses are prevalent in non-ventilated hospital-acquired pneumonia.

Shorr AF, Zilberberg MD, Micek ST, Kollef MH.

Respir Med. 2017 Jan;122:76-80. doi: 10.1016/j.rmed.2016.11.023. Epub 2016 Nov 29.

PMID:
27993295
13.

Going Viral: Importance of Viral Pathogens in Nonventilated Hospital-Acquired Pneumonia.

Shorr AF, Zilberberg MD.

Chest. 2016 Nov;150(5):991-992. doi: 10.1016/j.chest.2016.05.028. No abstract available.

PMID:
27832891
14.

Mortality and Costs in Clostridium difficile Infection Among the Elderly in the United States.

Shorr AF, Zilberberg MD, Wang L, Baser O, Yu H.

Infect Control Hosp Epidemiol. 2016 Nov;37(11):1331-1336. Epub 2016 Aug 30.

PMID:
27572289
15.

Dementia and Outcomes of Mechanical Ventilation.

Lagu T, Zilberberg MD, Tjia J, Shieh MS, Stefan M, Pekow PS, Lindenauer PK.

J Am Geriatr Soc. 2016 Oct;64(10):e63-e66. doi: 10.1111/jgs.14344. Epub 2016 Sep 7.

16.

Multidrug resistance, inappropriate empiric therapy, and hospital mortality in Acinetobacter baumannii pneumonia and sepsis.

Zilberberg MD, Nathanson BH, Sulham K, Fan W, Shorr AF.

Crit Care. 2016 Jul 11;20(1):221. doi: 10.1186/s13054-016-1392-4.

17.

Hearing Loss in Israeli Air Force Aviators: Natural History and Risk Factors.

Gordon B, Joachims Z, Cohen HB, Grossman A, Derazne E, Carmon E, Zilberberg M, Levy Y.

Mil Med. 2016 Jul;181(7):687-92. doi: 10.7205/MILMED-D-15-00289.

PMID:
27391623
18.

Development and Validation of a Risk Score for Clostridium difficile Infection in Medicare Beneficiaries: A Population-Based Cohort Study.

Zilberberg MD, Shorr AF, Wang L, Baser O, Yu H.

J Am Geriatr Soc. 2016 Aug;64(8):1690-5. doi: 10.1111/jgs.14236. Epub 2016 Jun 13.

PMID:
27295521
19.

Association Between Initial Route of Fluoroquinolone Administration and Outcomes in Patients Hospitalized for Community-acquired Pneumonia.

Belforti RK, Lagu T, Haessler S, Lindenauer PK, Pekow PS, Priya A, Zilberberg MD, Skiest D, Higgins TL, Stefan MS, Rothberg MB.

Clin Infect Dis. 2016 Jul 1;63(1):1-9. doi: 10.1093/cid/ciw209. Epub 2016 Apr 5.

20.

Appropriate Antibiotic Treatment in Severe Sepsis and Septic Shock: Timing Is Everything.

Zilberberg MD, Shorr AF.

Crit Care Med. 2015 Oct;43(10):2258-9. doi: 10.1097/CCM.0000000000001219. No abstract available.

PMID:
26376254

Supplemental Content

Loading ...
Support Center